CD24

Summary

Signal transducer CD24 also known as cluster of differentiation 24 or heat stable antigen CD24 (HSA) is a protein that in humans is encoded by the CD24 gene.[3] CD24 is a cell adhesion molecule.

CD24
Identifiers
AliasesCD24, CD24A, CD24 molecule
External IDsOMIM: 600074 GeneCards: CD24
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001291737
NM_001291738
NM_001291739
NM_013230
NM_001359084

n/a

RefSeq (protein)

NP_001278666
NP_001278667
NP_001278668
NP_037362
NP_001346013

n/a

Location (UCSC)Chr 6: 106.97 – 106.98 Mbn/a
PubMed search[2]n/a
Wikidata
View/Edit Human

Function edit

CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils[4] and neutrophil precursors from the myelocyte stage onwards. The encoded protein is anchored via a glycosyl phosphatidylinositol (GPI) link to the cell surface. The protein also contributes to a wide range of downstream signaling networks and is crucial for neural development.[5] Cross-linking of CD24 on the surface of neutrophils induces apoptosis,[6] and this appears to be defective in sepsis.[6] CD24 gene is found on chromosome 6 (6q21) An alignment of this gene's sequence finds genomic locations with similarity on chromosomes 1p36, 3p26, 15q21.3, 20q11.2 and Yq11.222. Whether transcription, and corresponding translation, occurs at each of these other genomic locations needs to be experimentally determined.[citation needed]

References edit

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000272398 – Ensembl, May 2017
  2. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. ^ Hough MR, Rosten PM, Sexton TL, Kay R, Humphries RK (July 1994). "Mapping of CD24 and homologous sequences to multiple chromosomal loci". Genomics. 22 (1): 154–61. doi:10.1006/geno.1994.1356. PMID 7959762.
  4. ^ Elghetany MT, Patel J (December 2002). "Assessment of CD24 expression on bone marrow neutrophilic granulocytes: CD24 is a marker for the myelocytic stage of development". American Journal of Hematology. 71 (4): 348–9. doi:10.1002/ajh.10176. PMID 12447971. S2CID 39674808.
  5. ^ Gilliam DT, Menon V, Bretz NP, Pruszak J (March 2017). "The CD24 surface antigen in neural development and disease". Neurobiology of Disease. 99: 133–144. doi:10.1016/j.nbd.2016.12.011. PMID 27993646. S2CID 3492300.
  6. ^ a b Parlato M, Souza-Fonseca-Guimaraes F, Philippart F, Misset B, Adib-Conquy M, Cavaillon JM (March 2014). "CD24-triggered caspase-dependent apoptosis via mitochondrial membrane depolarization and reactive oxygen species production of human neutrophils is impaired in sepsis". Journal of Immunology. 192 (5): 2449–59. doi:10.4049/jimmunol.1301055. PMID 24501201. S2CID 45838206.

Further reading edit

  • Li D, Zheng L, Jin L, Zhou Y, Li H, Fu J, Shi M, Du P, Wang L, Wu H, Chen GY, Zheng P, Liu Y, Wang FS, Wang S (September 2009). "CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection". Hepatology. 50 (3): 735–42. doi:10.1002/hep.23047. PMID 19610054. S2CID 34010521.
  • Piotrowski P, Lianeri M, Wudarski M, Łacki JK, Jagodziński PP (June 2010). "CD24 Ala57Val gene polymorphism and the risk of systemic lupus erythematosus". Tissue Antigens. 75 (6): 696–700. doi:10.1111/j.1399-0039.2010.01447.x. PMID 20230526.
  • Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A, Hegardt C (2008). "The CD44+/CD24- phenotype is enriched in basal-like breast tumors". Breast Cancer Research. 10 (3): R53. doi:10.1186/bcr2108. PMC 2481503. PMID 18559090.
  • Nagy B, Szendroi A, Romics I (June 2009). "Overexpression of CD24, c-myc and phospholipase 2A in prostate cancer tissue samples obtained by needle biopsy". Pathology & Oncology Research. 15 (2): 279–83. doi:10.1007/s12253-008-9077-1. PMID 18752058. S2CID 22572165.
  • Kim KH, Choi JS, Kim JM, Choi YL, Shin YK, Lee HC, Seong IO, Kim BK, Chae SW, Kim SH (March 2009). "Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium". Histology and Histopathology. 24 (3): 309–16. doi:10.14670/HH-24.309. PMID 19130400.
  • Buess M, Rajski M, Vogel-Durrer BM, Herrmann R, Rochlitz C (October 2009). "Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer". Neoplasia. 11 (10): 987–1002. doi:10.1593/neo.09670. PMC 2745665. PMID 19794958.
  • Pruszak J, Ludwig W, Blak A, Alavian K, Isacson O (December 2009). "CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells". Stem Cells. 27 (12): 2928–40. doi:10.1002/stem.211. PMC 3322476. PMID 19725119.
  • Liu Y, Chen GY, Zheng P (December 2009). "CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns". Trends in Immunology. 30 (12): 557–61. doi:10.1016/j.it.2009.09.006. PMC 2788100. PMID 19786366.
  • Vesuna F, Lisok A, Kimble B, Raman V (December 2009). "Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression". Neoplasia. 11 (12): 1318–28. doi:10.1593/neo.91084. PMC 2794513. PMID 20019840.
  • Sagiv E, Arber N (February 2008). "The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy". Expert Review of Gastroenterology & Hepatology. 2 (1): 125–33. doi:10.1586/17474124.2.1.125. PMID 19072375. S2CID 22336532.
  • Bauerschmitz GJ, Ranki T, Kangasniemi L, Ribacka C, Eriksson M, Porten M, Herrmann I, Ristimäki A, Virkkunen P, Tarkkanen M, Hakkarainen T, Kanerva A, Rein D, Pesonen S, Hemminki A (July 2008). "Tissue-specific promoters active in CD44+CD24-/low breast cancer cells". Cancer Research. 68 (14): 5533–9. doi:10.1158/0008-5472.CAN-07-5288. PMID 18632604.
  • Carl JW, Liu JQ, Joshi PS, El-Omrani HY, Yin L, Zheng X, Whitacre CC, Liu Y, Bai XF (July 2008). "Autoreactive T cells escape clonal deletion in the thymus by a CD24-dependent pathway". Journal of Immunology. 181 (1): 320–8. doi:10.4049/jimmunol.181.1.320. PMID 18566397. S2CID 10530971.
  • Baumhoer D, Riener MO, Zlobec I, Tornillo L, Vogetseder A, Kristiansen G, Dietmaier W, Hartmann A, Wuensch PH, Sessa F, Ruemmele P, Terracciano LM (February 2009). "Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater". Modern Pathology. 22 (2): 306–13. doi:10.1038/modpathol.2008.192. PMID 19043399. S2CID 36610531.
  • Wang W, Wang X, Peng L, Deng Q, Liang Y, Qing H, Jiang B (January 2010). "CD24-dependent MAPK pathway activation is required for colorectal cancer cell proliferation". Cancer Science. 101 (1): 112–9. doi:10.1111/j.1349-7006.2009.01370.x. PMID 19860845. S2CID 205235492.
  • Sano A, Kato H, Sakurai S, Sakai M, Tanaka N, Inose T, Saito K, Sohda M, Nakajima M, Nakajima T, Kuwano H (February 2009). "CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma". Annals of Surgical Oncology. 16 (2): 506–14. doi:10.1245/s10434-008-0252-0. PMID 19050962. S2CID 30259987.
  • Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH, Qin WX, Fan J (September 2009). "CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery". Clinical Cancer Research. 15 (17): 5518–27. doi:10.1158/1078-0432.CCR-09-0151. PMID 19706825. S2CID 15611706.
  • Lee JH, Kim SH, Lee ES, Kim YS (November 2009). "CD24 overexpression in cancer development and progression: a meta-analysis". Oncology Reports. 22 (5): 1149–56. doi:10.3892/or_00000548. PMID 19787233.
  • Gekara NO, Weiss S (November 2004). "Lipid rafts clustering and signalling by listeriolysin O". Biochemical Society Transactions. 32 (Pt 5): 712–4. doi:10.1042/BST0320712. PMID 15493995.
  • Athanassiadou P, Grapsa D, Gonidi M, Athanassiadou AM, Tsipis A, Patsouris E (2009). "CD24 expression has a prognostic impact in breast carcinoma". Pathology, Research and Practice. 205 (8): 524–33. doi:10.1016/j.prp.2009.01.008. PMID 19243896.
  • Ronaghi M, Vallian S, Etemadifar M (December 2009). "CD24 gene polymorphism is associated with the disease progression and susceptibility to multiple sclerosis in the Iranian population". Psychiatry Research. 170 (2–3): 271–2. doi:10.1016/j.psychres.2009.01.002. PMID 19896210. S2CID 35984512.
  • van de Peppel J, Schaaf G, Matos A, Guo Y, Strini T, Verschoor W, Dudakovic A, van Wijnen A, van Leeuwen J (March 2021). "Cell Surface Glycoprotein CD24 Marks Bone Marrow-Derived Human Mesenchymal Stem/Stromal Cells with Reduced Proliferative and Differentiation Capacity In Vitro". Stem Cells & Development. 30 (6): 325–336. doi:10.1089/scd.2021.0027. PMC 7984936. PMID 33593128.

External links edit